Clinical Trial Update: Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of levetiracetam to prevent relapse in recently detoxified alcohol-dependent patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Alcohol Dependence, Alcoholic Relapse | Phase 3 | Status: COMPLETED